Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03085095 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO) |
| First Submitted : | March 9, 2017 |
| First Submitted that Met QC Criteria : | March 14, 2017 |
| First Posted : | March 21, 2017 |
| Results First Submitted : | January 19, 2021 |
| Results First Posted with QC Comments : | February 15, 2021 |
| Results First Submitted that Met QC Criteria : | March 2, 2021 |
| Results First Posted : | March 25, 2021 |
| Certification/Extension First Submitted : | October 5, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | March 2, 2021 |
| Certification/Extension First Posted : | March 25, 2021 |
| Last Update Submitted that Met QC Criteria : | January 6, 2022 |
| Last Update Posted : | January 18, 2022 |